The p53 codon 72 polymorphism and risk of oral cancer in Southern Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 4, Issue 3, 2003, Pages 209-214

  Kietthubthew, Suparp ^a   Sriplung, Hutcha ^a   Au, William W ^b   Ishida, Takafumi ^c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alcohol consumption; Betel chewing; Genetic susceptibility; Oral cancer; P53 codon 72 polymorphism; Tobacco smoking

Indexed keywords

AGED; ARTICLE; CODON; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; MOUTH TUMOR; RISK FACTOR; THAILAND; TUMOR SUPPRESSOR GENE;

AGED; CODON; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; THAILAND;

EID: 0642279569     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Balaram P, Sridhar N, Rajkumar T, et al (2002). Oral cancer in Southern India, the influence of smoking, drinking, paanchewing and oral hygiene. Int J Cancer, 98, 440-5.
2. Connor DPO, Kay EW, Leader M, et al (2001). p53 codon 72 polymorphism and human papilloma virus associated skin cancer. J Clin Pathol, 54, 539-42.
3. Guimaraes DP, Lu SH, Snijders P, et al (2001). Abscence of association between HPV DNA, TP 53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Letters, 162, 231-5.
4. Hamel N, Black MJ, Ghadirian P, Foulkes WD (2000). No association between p53 codon 72 polymorphism and risk of squamous ccell caarcinoma of the head and neck. Br J Cancer,82, 757-9.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991). P53 mutation in human cancer. Science, 253, 49-53.
6. Hsieh LL, Wang PF, Chen IH, et al (2001). Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis, 22, 1497-503.
7. Kerdpon D, Sriplung H, Kietthubthew S (2001). Expression of p53 in oral squamous cell carcinoma and its association with risk habbits in southern Thailand. Oral Oncol, 37, 553-7.
8. Kietthubthew S, Sriplung H, Au WW (2001). Genetic and environmental interactions on oral cancer in southern Thailand. Environ Mol Mutagen, 37, 111-6.
9. Ko YC, Huang YL, Lee CH, et al (1995). Betel quid chewing, cigarette smoking, and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med, 24, 450-3.
10. Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T (2003). p53 codon 72 polymorphism and urothelial cancer risk. Cancer Letters, 187, 77-83.
11. Lee JM, Lee YC, Yang SY, et al (2000). Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous cell carcinoma of the esophagus. Int J Cancer (Pred Oncol), 89, 458-64.
12. Levine AJ (1997). P53, the cellular gatekeeper for growth and division. Cell, 88, 323.
13. Partridge M, Kiguwa S, Emilion G, et al (1999). New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncol, 35, 45-55.
14. Marin MC, Jost CA, Brooks LA (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behavior. Nature Genetics, 25, 47-54.
15. Matlashewski GJ, Tuck S, Pim D, et al (1987). Primary structure of polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 7, 961-3.
16. McWilliams JE, Evans AJ, Beer TM, et al (2000). Genetic polymorphisms in head and neck cancer risk. Head Neck, 22, 609-17.
17. Miller CS and Johnstone BONE MARROW (2001). Human papilloma virus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Ora Med Oral Pathol Oral Radiol Endod, 91, 622-35.
18. Nagpal JK, Patnaik S, Das BR (2002). Prevalence of high-risk human papilloma virus types and its association with p53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer, 95, 649-53.
19. Oswald C, Gogacz P, Hillmann T, et al (2000). p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer, 88, 82-6.
20. Sambrook J, Fritsch EF, Maniatis T (1989). Molecular cloning: a laboratory manual. 2nd edition. Cold Spring Harbor Laboratory Press, New York pp 9.16-9.18.
21. Schwartz SM, JR Daling, DR Doody, et al (1998). Oral cancer risk in relation to sexual history and evidence of human papilloma virus infection. J Natl Cancer Inst, 90, 1626-36.
22. Sciubba JJ (2000). Oral cancer. The importance of early diagnosis and treatment, Am J Clin Dermatol, 2, 239-51.
23. Scully C and Bedi R (2000). Ethnicity and oral cancer. Lancet Oncol, 1, 37-42.
24. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q (2000). P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case control study, Cancer Letters, 183, 123-30.
25. Sreelekha TT, Ramadas K, Pandey M, et al (2001). Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer, Oral Oncol, 37, 593-8.
26. Srivatanakul P, Deerasamee S, Parkin DM (1999). Introduction. In "Cancer in Thailand Vol. II, 1992-1994" Eds Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung H, Srivatanakul P, Vatanasapt V, Parkin D.M, Ferlay J. IARC Technical Report 34, IARC, Lyon pp 24.
27. Storey A, Thomas M, Kalita A, et al (1998). Role of a p53 polymorphism in the development of human papilloma virusassociated cancer. Nature, 93, 229-34.
28. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP (2000). p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral. Surg Oral Med Oral Pathol Oral Radiol Endod, 90, 334-9.
29. Tandle AT, Sanghvi V, Saranath D (2001). Determination of p53 genotypes in oral cancer patients from India. Br J Cancer, 84, 739-42.
30. Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100.
31. Topcu Z, Chiba I, Fujieda M, et al (2002). CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis, 23, 595-8.
32. Tsai MH, Lin CD, Hsieh YY, et al (2002). Prognostic significance of the Proline form of the p53 codon 72 in nasopharyngeal carcinoma. Laryngoscope, 112, 116-9.